Costimulatory Molecules as Biomarkers in Cystic Fibrosis

Completed

• Conditions: Cystic Fibrosis

• Registration Number: NCT01353950
• Lead Sponsor: Oregon Health and Science University

Brief Summary

The purpose of this study is to investigate the expression of a certain class of molecules, called costimulatory molecules, in humans with Cystic Fibrosis. Cystic Fibrosis is a genetic disorder which renders the lung susceptible to persistent inflammation which, at times, can worsen, resulting in accelerated decline in lung function and eventually death or transplant. Our goal is to determine if the levels of costimulatory markers can be used to predict exacerbation and subsequent lung function decline in subjects with Cystic Fibrosis.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-05-12
• Study First Submitted QC: 2011-05-13
• Study First Posted: 2011-05-16
• Study Start: 2011-07
• Primary Completion: 2013-06
• Study Completion: 2013-06
• Status Verified: 2017-04
• Last Update Submitted: 2017-04-04
• Last Update Posted: 2017-04-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Willingness to participate

Exclusion Criteria

• Presence of HIV
• Presence of Lymphoma/Leukemia
• Presence of Lung or other solid organ Transplant
• Pregnancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Oregon health and Sciences University; 🇺🇸 Portland, Oregon, United States